CHEBI:62287 - α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc
ChEBI ID CHEBI:62287
ChEBI ASCII Name alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc
Definition An amino trisaccharide consisting of N-acetylglucosamine having a fucosyl residue attached at the 3-position via an α-linkage and a galactosyl residue attached at the 4-position via a β-linkage.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information No supplier information found for this compound.
Download Molfile XML SDF
Formula C20H35NO15
Net Charge 0
Average Mass 529.48960
Monoisotopic Mass 529.20067
InChI InChI=1S/C20H35NO15/c1-5-10(25)12(27)14(29)19(32-5)36-17-9(21-6(2)24)18(31)33-8(4-23)16(17)35-20-15(30)13(28)11(26)7(3-22)34-20/h5,7-20,22-23,25-31H,3-4H2,1-2H3,(H,21,24)/t5-,7+,8+,9+,10+,11-,12+,13-,14-,15+,16+,17+,18?,19-,20-/m0/s1
InChIKey HBBOZFUQJDYASD-QGTNPELVSA-N
SMILES C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(C)=O)C(O)O[C@H](CO)[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@@H]1O
Roles Classification
Biological Role(s): antigen
Any substance that stimulates an immune response in the body, such as through antibody production or by presentation to a T-cell receptor after binding to a major histocompability complex (MHC).
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287) has role antigen (CHEBI:59132)
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287) has role epitope (CHEBI:53000)
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287) is a amino trisaccharide (CHEBI:59266)
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287) is a glucosamine oligosaccharide (CHEBI:22485)
Incoming α-L-Fucp-(1→3)-[α-L-Fucp-(1→3)-β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:148911) has functional parent α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287)
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-β-D-GlcpNAc (CHEBI:59294) is a α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287)
β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-D-glucosaminyl group (CHEBI:17995) is substituent group from α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc (CHEBI:62287)
IUPAC Name
α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-D-glucopyranose
Synonyms Sources
(Gal)1 (GlcNAc)1 (LFuc)1 KEGG GLYCAN
3-FL KEGG GLYCAN
3-Fucosyllactosamine KEGG GLYCAN
6-deoxy-α-L-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-acetamido-2-deoxy-D-glucopyranose IUPAC
α-L-Fuc-(1→3)-[β-D-Gal-(1→4)]-D-GlcNAc ChEBI
α-L-fucopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→4)]-2-(acetylamino)-2-deoxy-D-glucopyranose IUPAC
α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-D-glucosamine ChEBI
α-L-Fucp-(1→3)-[β-D-Galp-(1→4)]-D-GlcpNAc ChEBI
β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-D-GlcNAc ChEBI
β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-D-glucosamine ChEBI
β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-D-glucosamine UniProt
Galβ1-4(Fucα1-3)GlcNAc ChEBI
Lewis x antigen KEGG GLYCAN
Lewisx ChEBI
Lex ChEBI
Lex ChEBI
Tetraantennary neutral lactosaminoglycan KEGG GLYCAN
WURCS=2.0/3,3,2/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5]/1-2-3/a3-b1_a4-c1 GlyTouCan
Manual Xrefs Databases
G00243 KEGG GLYCAN
G01187XC GlyGen
G01187XC GlyTouCan
View more database links
Registry Number Type Source
6080155 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
12788923 PubMed citation Europe PMC
12932753 PubMed citation Europe PMC
16133831 PubMed citation Europe PMC
2125273 PubMed citation Europe PMC
22241826 PubMed citation Europe PMC
23724317 PubMed citation Europe PMC
2405185 PubMed citation Europe PMC
2430018 PubMed citation Europe PMC
2908539 PubMed citation Europe PMC
32568414 PubMed citation Europe PMC
6083446 PubMed citation Europe PMC
6208947 PubMed citation Europe PMC
7792271 PubMed citation Europe PMC
7912739 PubMed citation Europe PMC
8532688 PubMed citation Europe PMC
9649244 PubMed citation Europe PMC
9649245 PubMed citation Europe PMC
Last Modified
22 February 2022